(Total Views: 509)
Posted On: 12/11/2019 3:43:53 PM
Post# of 72446
The following was in IBD News Weekly Digest in September. This is a paid site but I included the headline for those that want to follow up on it.
———————————-
IBD Updates
Contents:
Innovation Pharma Planning 1st Clinical Trial of Oral Brilacidin as Potential Ulcerative Colitis Treatment
Sep 20, 2019 07:00 am | Joana Carvalho, MSc
Innovation Pharmaceuticals is planning a first clinical trial of an oral formulation of Brilacidin as a treatment for ulcerative colitis (UC), one of the most common types of inflammatory bowel disease (IBD). Brilacidin is a synthetic small molecule that belongs to a new class of compounds known as defensin-mimetics. It is structurally similarity to proteins naturally produced in […]
The post Innovation Pharma Planning 1st Clinical Trial of Oral Brilacidin as Potential Ulcerative Colitis Treatment appeared first on IBD News Today.
———————————-
IBD Updates
Contents:
Innovation Pharma Planning 1st Clinical Trial of Oral Brilacidin as Potential Ulcerative Colitis Treatment
Sep 20, 2019 07:00 am | Joana Carvalho, MSc
Innovation Pharmaceuticals is planning a first clinical trial of an oral formulation of Brilacidin as a treatment for ulcerative colitis (UC), one of the most common types of inflammatory bowel disease (IBD). Brilacidin is a synthetic small molecule that belongs to a new class of compounds known as defensin-mimetics. It is structurally similarity to proteins naturally produced in […]
The post Innovation Pharma Planning 1st Clinical Trial of Oral Brilacidin as Potential Ulcerative Colitis Treatment appeared first on IBD News Today.
(8)
(1)
